242 related articles for article (PubMed ID: 26207710)
1. Optimal Topical Agent for Radiation Dermatitis During Breast Radiotherapy: A Pilot Study.
Fenton-Kerimian M; Cartwright F; Peat E; Florentino R; Maisonet O; Budin W; Rolnitzky L; Formenti S
Clin J Oncol Nurs; 2015 Aug; 19(4):451-5. PubMed ID: 26207710
[TBL] [Abstract][Full Text] [Related]
2. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
Kong M; Hong SE
Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
Zhao H; Zhu W; Jia L; Sun X; Chen G; Zhao X; Li X; Meng X; Kong L; Xing L; Yu J
Br J Radiol; 2016; 89(1058):20150665. PubMed ID: 26607642
[TBL] [Abstract][Full Text] [Related]
4. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Acceptability of a Moisturizing Cream and a Barrier Cream During Radiation Therapy for Breast Cancer in the Tropics: A Randomized Controlled Trial.
Laffin N; Smyth W; Heyer E; Fasugba O; Abernethy G; Gardner A
Cancer Nurs; 2015; 38(3):205-14. PubMed ID: 24945268
[TBL] [Abstract][Full Text] [Related]
6. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
Ulff E; Maroti M; Serup J; Falkmer U
Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced Skin Toxicity in Breast Cancer Patients: A Systematic Review of Randomized Trials.
Yee C; Wang K; Asthana R; Drost L; Lam H; Lee J; Vesprini D; Leung E; DeAngelis C; Chow E
Clin Breast Cancer; 2018 Oct; 18(5):e825-e840. PubMed ID: 30072193
[TBL] [Abstract][Full Text] [Related]
8. A case-control, mono-center, open-label, pilot study to evaluate the feasibility of therapeutic touch in preventing radiation dermatitis in women with breast cancer receiving adjuvant radiation therapy.
Younus J; Lock M; Vujovic O; Yu E; Malec J; D'Souza D; Stitt L
Complement Ther Med; 2015 Aug; 23(4):612-6. PubMed ID: 26275655
[TBL] [Abstract][Full Text] [Related]
9. Retrospective study of radiotherapy-induced skin reactions in breast cancer patients: reduced incidence of moist desquamation with a hydroactive colloid gel versus dexpanthenol.
Censabella S; Claes S; Orlandini M; Braekers R; Thijs H; Bulens P
Eur J Oncol Nurs; 2014 Oct; 18(5):499-504. PubMed ID: 24877859
[TBL] [Abstract][Full Text] [Related]
10. Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis.
Rollmann DC; Novotny PJ; Petersen IA; Garces YI; Bauer HJ; Yan ES; Wahner-Roedler D; Vincent A; Sloan JA; Issa Laack NN
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):650-8. PubMed ID: 25936812
[TBL] [Abstract][Full Text] [Related]
11. [Efectiveness of topical therapies in patients with breast cancer that experience radiodermatitis. A systematic review].
Fernández-Castro M; Martín-Gil B
Enferm Clin; 2015; 25(6):327-43. PubMed ID: 26475084
[TBL] [Abstract][Full Text] [Related]
12. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
Ghasemi A; Ghashghai Z; Akbari J; Yazdani-Charati J; Salehifar E; Hosseinimehr SJ
Eur J Clin Pharmacol; 2019 Feb; 75(2):171-178. PubMed ID: 30291370
[TBL] [Abstract][Full Text] [Related]
13. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study.
Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F
G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571
[TBL] [Abstract][Full Text] [Related]
14. Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study.
Schmuth M; Wimmer MA; Hofer S; Sztankay A; Weinlich G; Linder DM; Elias PM; Fritsch PO; Fritsch E
Br J Dermatol; 2002 Jun; 146(6):983-91. PubMed ID: 12072066
[TBL] [Abstract][Full Text] [Related]
15. Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?
Röper B; Kaisig D; Auer F; Mergen E; Molls M
Strahlenther Onkol; 2004 May; 180(5):315-22. PubMed ID: 15127162
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy.
Zhu W; Jia L; Chen G; Zhao H; Sun X; Meng X; Zhao X; Xing L; Yu J; Zheng M
Oncotarget; 2016 Jul; 7(30):48607-48613. PubMed ID: 27224910
[TBL] [Abstract][Full Text] [Related]
17. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
Zenda S; Yamaguchi T; Yokota T; Miyaji T; Mashiko T; Tanaka M; Yonemura M; Takeno M; Okano T; Kawasaki T; Nakamori Y; Ishii S; Shimada S; Kanamaru M; Uchitomi Y
BMC Cancer; 2018 Sep; 18(1):873. PubMed ID: 30189840
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13.
Fisher J; Scott C; Stevens R; Marconi B; Champion L; Freedman GM; Asrari F; Pilepich MV; Gagnon JD; Wong G
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1307-10. PubMed ID: 11121627
[TBL] [Abstract][Full Text] [Related]
19. Prophylactically applied Hydrofilm polyurethane film dressings reduce radiation dermatitis in adjuvant radiation therapy of breast cancer patients.
Schmeel LC; Koch D; Stumpf S; Leitzen C; Simon B; Schüller H; Vornholt S; Schoroth F; Müdder T; Röhner F; Garbe S; Schmeel FC; Schild HH; Wilhelm-Buchstab TM
Acta Oncol; 2018 Jul; 57(7):908-915. PubMed ID: 29463159
[TBL] [Abstract][Full Text] [Related]
20. Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer.
Hemati S; Asnaashari O; Sarvizadeh M; Motlagh BN; Akbari M; Tajvidi M; Gookizadeh A
Support Care Cancer; 2012 Aug; 20(8):1613-8. PubMed ID: 22006502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
